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Evaluation of Genetic Variation Contributing
to Differences in Gene Expression between Populations
Wei Zhang,1,5 Shiwei Duan,1,5 Emily O. Kistner,2 Wasim K. Bleibel,1 R. Stephanie Huang,1
Tyson A. Clark,4 Tina X. Chen,4 Anthony C. Schweitzer,4 John E. Blume,4 Nancy J. Cox,1,3
and M. Eileen Dolan1,*
Gene expression is a complex quantitative trait partially regulated by genetic variation in DNA sequence. Population differences in gene
expression could contribute to some of the observed differences in susceptibility to common diseases and response to drug treatments.
We characterized gene expression in the full set of HapMap lymphoblastoid cell lines derived from individuals of European and African
ancestry for 9156 transcript clusters (gene-level) evaluated with the Affymetrix GeneChip Human Exon 1.0 ST Array. Gene expression
was found to differ signiﬁcantly between these samples for 383 transcript clusters. Biological processes including ribosome biogenesis
and antimicrobial humoral response were found to be enriched in these differential genes, suggesting their possible roles in contributing
to the population differences at a higher level than that of mRNA expression and in response to environmental information. Genome-
wide association studies for local or distant genetic variants that correlate with the differentially expressed genes enabled identiﬁcation
of signiﬁcant associations with one ormore single-nucleotide polymorphisms (SNPs), consistent with the hypothesis that genetic factors
and not simply population identity or other characteristics (age of cell lines, length of culture, etc.) contribute to differences in gene
expression in these samples. Our results provide a comprehensive view of the genes differentially expressed between populations and
the enriched biological processes involved in these genes. We also provide an evaluation of the contributions of genetic variation
and nongenetic factors to the population differences in gene expression.Introduction
The genetic basis for population differences in clinical
outcome and risk of disease is not fully understood.1–5
Although contributors to the differences are likely to
include socioeconomic and/or environmental factors,
genetic variation affecting gene-expression levels is likely
to play an important role. Previous studies have shown
that gene expression is a complex quantitative phenotype
with variability among individuals as well as among cell
types.6–8 The International HapMap resource,9,10 which in-
cludes information on millions of single-nucleotide poly-
morphisms (SNPs) genotyped in lymphoblastoid cell lines
(LCLs) for the individuals included in HapMap, and the
availability of these LCLs enable whole genome expression
studies and characterization of the genetic contribution of
the SNPs to the variation in gene expression observed be-
tween individuals.11 Common genetic variants accounting
for interindividual differences in gene expression have
been reported with the use of a panel of LCLs, derived
from individuals of European ancestry fromUtah, USA, col-
lected by Centre d’Etude du Polymorphisme Humain
(CEPH).8,12–14
However, population differences in gene expression
have only recently begun to be investigated. Spielman
et al. utilized a subset of human genes (~4,200 expressed
in LCLs and queried by the Affymetrix HG-Focus array),
with samples derived from unrelated CEPH individuals
from Utah, USA (CEU) and from Han Chinese individualsin Beijing and Japanese individuals in Tokyo (CHB/JPT), to
demonstrate that cis-acting regulators may account for
some of the population differences in gene expression,15
although Akey et al. suggested that batch effects could be
a confounding factor when interpreting their results.16
Using the same microarray platform, Storey et al. showed
that 17% of genes are differentially expressed between
CEU individuals and Yoruba individuals from Ibadan,
Nigeria (YRI) in a set of 16 unrelated samples.17 To compre-
hensively investigate the pattern of population differences
in gene expression, we utilized the Affymetrix GeneChip
Human Exon 1.0 ST Array (exon array), which contains
~20,000 known human genes (~1.4 million annotated
and predicted exons corresponding to 17,879 transcript
clusters with the core set of exons used), to study a set of
HapMap samples consisting of 30 CEU and 30 YRI par-
ents-offspring trios. Our goals were to determine gene-
expression differences between these two populations, to
identify what biological processes or pathways are en-
riched in the differentially expressed genes, and to evaluate
the contribution of local and distant genetic variation to
population differences in gene expression. Because of the
fact that the Epstein-Barr virus (EBV)-transformation of
LCLs from the CEU and the YRI samples occurred more
than 20 years apart,10,18 certain nongenetic factors, such
as the EBV strains used for transformation or the number
of freeze/thaw cycles, could lead to differences in gene
expression between these two populations. Therefore, we
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contribution of genetic variation to gene-expression differ-
ences relative to other nongenetic factors.
Material and Methods
Cell Lines
HapMap9,10 cell lines (30 CEU trios and 30 YRI trios) were pur-
chased from the Coriell Institute for Medical Research (Camden,
NJ). The order in which the cell lines were processed was balanced
with respect to population in an effort to minimize variation in
growth conditions between populations (a potentially confound-
ing factor). On the same day that ten YRI-population cell lines
were received as live cultures from Coriell, a set of ten CEU lines
were thawed at our facility; both sets were centrifuged at
400 3 g to remove media. Five milliliters of lymphoblastoid cell
medium (LCL medium) consisting of RPMI 1640 (Mediatech) sup-
plemented with 1% l-glutamine (Mediatech) and 20% FBS (Hy-
Clone Laboratories, Lot # AQF24010) was added for the initial pas-
sage and then cells were passaged every 48 hr with LCL medium
and 15% FBS. Cell suspensions were transferred to 25 cm2 ﬂasks
and incubated at 37C in a 90% humidiﬁed, 5% CO2 atmosphere.
Both sets of YRI and CEU lines were maintained for three passages
at a concentration of 3.5–4.0 3 105 cells/mL and, if viability was
R85%, harvested after the fourth dilution from exponentially
growing cells. Cell suspensions were spun at 400 3 g for 5 min
to remove media. Cell pellets were washed twice with ice-cold
PBS (Invitrogen) and stored at 80C. Two CEU samples
(GM10855 and GM12236) were not available from Coriell at the
time of the study. The viability of two lines (GM12716,
GM18871) was below 85% at the sample-collection time and
therefore excluded from further analysis. A total of 176 cell lines
(87 CEU samples and 89 YRI samples) were included in this study.
RNA Isolation
Cell pellets were thawed and total RNA was extracted with
QIAGEN Qiashredder and RNeasy plus kits (QIAGEN) according
to the manufacturer’s protocol. RNA concentration and purity
was determined through measurement of A260/A280 ratios with
the Spectronic Genesys 6 UV/Vis Spectrophotometer (Thermo
Electron). Conﬁrmation of RNA quality was assessed by use of
the Agilent 2100 Bioanalyzer (Agilent Technologies). All 176
RNA samples had high quality and showed no signs of DNA con-
tamination or RNA degradation. RNA samples were immediately
frozen and stored at 80C.
Chip Hybridization
For each cell line, ribosomal RNA was depleted from 1 mg of total
RNA with the RiboMinus Human/Mouse Transcriptome Isolation
kit (Invitrogen). cDNA was generated with the GeneChip WT
cDNA Synthesis and Ampliﬁcation Kit (Affymetrix) per manufac-
turer’s instructions. cDNA was fragmented and end labeled with
the GeneChip WT Terminal Labeling Kit (Affymetrix). Approxi-
mately 5.5 mg of labeled DNA target was hybridized to the Affyme-
trix GeneChip Human Exon 1.0 ST Array at 45C for 16 hr per
manufacturer’s recommendation. Hybridized arrays were washed
and stained on a GeneChip Fluidics Station 450 and scanned on
a GCS3000 Scanner (Affymetrix). Previous studies using princi-
pal-component analysis (PCA) clustering on ﬁve technical repli-
cates for each RNA sample, taken from three different passages
from two cell lines, indicated that technical replicates group632 The American Journal of Human Genetics 82, 631–640, Marchtogether very tightly.19 We did not perform replicates; however,
data for technical replicates from the Affymetrix website indicates
an average Pearson correlation coefﬁcient of greater than 0.995
and a coefﬁcient of variation of 7.2%.20
Data Filtering for SNPs in Probes, Signal
Normalization, and Summarization
Expression arrays were analyzed with Partek GS Exon Array soft-
ware (Partek, St. Louis, MO). The start and end coordinates of all
probes represented on the exon array were queried and deter-
mined against the human genome (hg17). The coordinates for
all SNPs were then queried in the dbSNP database (release 126)
and used to identify probes harboring SNPs. In total, >400,000
probes within 255,676 unique probesets (of the ~1.4 million pro-
besets on the exon array) contained SNPs within their structures.
Among these affected probesets, 105,000 harbored two or more
probes with SNPs. These 105,000 probesets and their correspond-
ing probes were then ﬁltered from all samples. After ﬁltering,
individual probe intensities were background corrected, by sub-
traction of the median intensity of a population of nongenomic
probes with the same GC content, to account for any nonspeciﬁc
hybridization. The resulting probe signal intensities were quantile
normalized over all 176 samples. Probeset-level expression signals
were summarized with the robust multi-array average (RMA)
method21. A constant of 16 was added to all probeset intensities
for variance stabilization, and summarized signals were then
log2 transformed with a median polish. We generated the expres-
sion signals of the 17,879 transcript clusters (gene-level) with the
core set (i.e., with RefSeq-supported annotation) of exons used
(~200,000) by taking averages of all annotated probesets (exon-
level) for each transcript cluster. We considered a transcript cluster
to be reliably expressed in LCLs if the log2-transformed expression
signal was > 6 in at least 90% of the 176 samples. 9156 transcript
clusters met these criteria and were further analyzed.
Identifying Differentially Expressed Genes
with the Westfall-Young Approach
We used the free step-down approach of Westfall-Young (W-Y
approach),22 which is commonly known as a permutation-based
family-wise error rate (FWER) correction approach, to identify dif-
ferentially expressed transcript clusters between the CEU and YRI
samples. The W-Y approach takes the dependence structure
between genes into account, which is especially relevant when
one is interested in genes that are involved in the same biological
process or pathway. The basic test used is the standard pooled-var-
iance t statistic. Because gene expression from individuals within
the same trio may be correlated, trios were permuted between
the CEU and YRI samples. The W-Y approach (10,000 permuta-
tions) was then used to compute simultaneous p values that con-
trol the overall error rate or FWER. This is equivalent to assuming
that the trios are independent and that membership is deﬁned at
the trio-level. The transcript clusters with a signiﬁcant permuta-
tion-adjusted p value (Pc < 0.01) were chosen for further analyses.
The permutation-adjusted one-sided p values were calculated with
the Permax 2.2 software, which was provided as a contributory
library by Robert Gray in the R statistical package.23
Identifying Differentially Expressed Genes
with a General Linear Model
We also used a general linear model constructed to reﬂect the trio
relationships in our data to identify differentially expressed2008
transcript clusters between the CEU and YRI samples. Trios were
treated as units of analysis, and members of different families
were considered independent. The covariance structure within
a trio was modeled via a Toeplitz structure with two diagonal
bands, with the trios ordered by father, offspring, then mother.
With this covariance structure, mother and father gene-expression
levels are independent but the offspring’s value is allowed to
covary with both the father’s and the mother’s values. In order
to reduce the number of false-positive results, a Bonferroni correc-
tion (Pc < 0.05) was used. Differential genes with this stringent
cutoff were used in further analysis. In addition to the Bonferroni
correction, the less-conservative QVALUE24 (default settings, Pc <
0.01) was used to provide an estimate of the lower-bound propor-
tion of true nulls (p0) for comparison. All models were pro-
grammed with the PROC MIXED procedure in SAS/STAT software
version 9.1 (SAS Institute). The REPEATED statement was used to
model the Toeplitz covariance structure.
Chromosomal Distribution of Differential Genes
Distribution of the transcript clusters differentially expressed be-
tween the CEU and YRI samples were tested against the null chro-
mosomal distribution of the analysis set of 9156 core transcript
clusters. Signiﬁcant chromosomes were determined with binomial
tests (Pc< 0.05 after Bonferroni correction). The chromosomal dis-
tribution of the differentially expressed transcript clusters was
plotted with STRIPE.25
Cluster Analysis
For the genes that were found to differ in expression between the
CEU and YRI samples, the Pearson correlation coefﬁcients of the
expression levels were computed for the 176 samples to represent
pairwise similarity. The samples were then grouped by a hierarchi-
cal clustering algorithm26 using the average linkage method,
which was implemented in the MeV:MultiExperiment Viewer
(TIGR).
GO and KEGG Pathway Analyses
We used Onto-Express27–29 to identify enriched Gene Ontology
(GO)30 biological processes among the differentially expressed
genes. Only well-characterized genes (excluding hypothetical pro-
teins) were included in the analysis. GO terms that were overrep-
resented relative to the analysis set of 9156 core transcript clusters
(corresponding to 8498 well-characterized genes) were selected
(three or more hits, binomial test Pc < 0.05 after Benjamini-Hoch-
berg [BH] correction31). Similarly, enriched Kyoto Encyclopedia of
Genes and Genomes (KEGG)32 pathways among the differentially
expressed genes relative to the analysis set were identiﬁed by Path-
way-Express27–29 (three hits or more, binomial test Pc < 0.05 after
BH correction).
Fst Values
Fst, a metric representation of the effect of population subdivision,
was estimated according to Wright’s approximate formula,
Fst ¼ ðHT HSÞ=HT , where HT represents expected heterozygosity
per locus of the total population and HS represents expected het-
erozygosity of a subpopulation.33 An Fst value was calculated for
each SNP of interest with allele frequencies estimated from the
unrelated individuals in each population.TheGenotype Data for the HapMap Samples
SNP genotypes were downloaded from the International HapMap
Project database (released July 21, 2006). SNPs with any Mende-
lian allele-transmission errors on 22 autosomes in the CEU or
YRI samples were discarded to reduce the effect of possible geno-
typing errors. The ﬁnal genotype dataset comprised 2,098,437
and 2,286,186 common SNPs (minor-allele frequency > 5%) in
the CEU and YRI samples, respectively.
Identifying Local or Distant Genetic Variants
that Regulate Gene Expression
The expression quantitative-trait loci (eQTLs) studies were ana-
lyzed with the QTDT software,34,35 which integrated SNPs and
the differentially expressed transcript clusters between the CEU
and YRI samples. The association study was carried out with
gene expression in the CEU or YRI samples with gender as a cova-
riate (QTDT p< 2.33 108, Pc < 0.05 after Bonferroni correction).
We deﬁned a gene as locally associated if the gene expression was
associated with any SNP within 2.5 Mb on the same chromosome,
whereas a gene was deﬁned as distantly associated if the gene
expression was associated with any SNP on different chromo-
somes or more than 2.5 Mb away on the same chromosome.
Evaluation of Genetic Variation and Nongenetic
Factors Contributing to Population Differences
in Expression
For a subset of moderate eQTLs (QTDT p < 0.001, including all
local and distant high-frequency SNPs having at least two counts
for each genotype), a reduced QTDTmodel was tested with gender
as a covariate. Likelihood-ratio tests comparing the QTDT, with
both population identity and gender as covariates, to the reduced
QTDT were computed to test whether population identity re-
mained a signiﬁcant predictor of gene expression when the associ-
ation between genotype and expression was modeled.
Results
Identifying Differentially Expressed
Genes between Populations
Of the 9156 transcript clusters, 410 (4.5%) showed signiﬁ-
cantly different expression between the CEU and YRI
samples by the t test-based W-Y approach (permutation-
adjusted Pc < 0.01). Among these 410 transcript clusters,
156 had higher expression levels in the CEU samples and
254 had higher expression levels in the YRI samples. Of
the 9156 transcript clusters, 464 (5.1%), including 156
with higher expression in CEU samples and 308 with
higher expression in YRI samples, were found to be differ-
entially expressed by the general linear model with a Toe-
plitz form for modeling parents-offspring trios (Pc < 0.05
after Bonferroni correction). With both of these indepen-
dent statistical approaches used, 383 transcript clusters
(4.2%) showed signiﬁcantly different expression between
the CEU and YRI samples (Table S1, available online). We
found that 3136 genes (34%) were differential between
the two populations at false discovery rate (FDR ¼ 1%)
by using the QVALUE software24 (Table S2). However, the
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set of p values, Storey et al. have shown that an estimate of
the overall proportion of differentially expressed genes can
be obtained without the requirement to set a subjective
threshold.24 When doing this, we found that 67% of the
genes were differentially expressed between the two popu-
lations (p0 ¼ 0.33 with default settings of the QVALUE24
software). Possible explanations for the discrepancy be-
tween our estimate, obtained with QVALUE, and the pro-
portion of differential genes reported by Storey et al.17
(17%) could be the much larger sample size used in our
study and/or other nongenetic factors, which we tried to
evaluate by testing a residual model.
Chromosomal Distribution of Differential Genes
Figure 1 shows the chromosomal distribution of these 383
transcript clusters. Although four chromosomes had nomi-
nally signiﬁcantpvalues (p<0.05), atPc<0.05after Bonfer-
roni correction chromosomes were not overrepresented or
Figure 1. Chromosomal Distribution of Differentially
Expressed Genes
The chromosomal distribution of the 383 transcript clusters
differentially expressed between the CEU and YRI samples.
247 transcript clusters (blue) showed higher levels of expres-
sion in the YRI samples, whereas 136 transcript clusters (red)
showed higher levels of expression in the CEU samples.
Figure 2. Clustering of Differentially Expressed Genes
Hierarchical clustering of the 383 differentially expressed transcript clusters (rows) and the 176 HapMap samples (columns). Red indi-
cates higher expression and green indicates lower expression. The top panel is the two-way hierarchical clustering of the 383 transcript
clusters and the 176 samples. The bottom panel is the tree view of the grouped samples. One of the two major distinguished groups
consists of 71 CEU samples and 3 YRI samples, and the other group consists of 86 YRI samples and 16 CEU samples.
underrepresented relative to the null distribution of the
transcript clusters in the analysis set.
Cluster Analysis
Figure 2 shows the results of the cluster analysis on the
383 differential transcript clusters between the CEU
and YRI samples. The cluster analysis grouped the 176
samples into two major distinguishable groups, in which
the CEU samples were generally separated from the YRI
samples with only a few exceptions. The cluster analysis
results conﬁrmed that the population identity was a deter-
ministic variable for the differences in expression for these
genes.
GO and KEGG Pathway Analyses
With the analysis set as background, two GO biological
processes were found to be enriched in the 383 transcript
clusters (corresponding to 388 well-characterized genes):
ribosome biogenesis (p ¼ 3.6 3 103, Pc < 0.05 after BH
correction) and antimicrobial humoral response (sensu
Vertebrata) (p ¼ 2.7 3 103, Pc < 0.05 after BH correction)
(Table 1). In contrast, at Pc < 0.05 no enriched KEGG path-
ways were identiﬁed in the differential genes.
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Identifying Local or Distant Genetic Variants
that Associate with Gene Expression
Association with >2,000,000 HapMap9,10 SNPs was eval-
uated in the CEU and YRI samples with the QTDT
software.34,35 In CEU and YRI, we identiﬁed six and ﬁve
transcript clusters, respectively, whose expression was
shown to be correlated with local SNPs (p < 2.3 3 108,
Pc< 0.05 after Bonferroni correction, Table S3). In addition,
we identiﬁed 18 transcript clusters in CEU and 46 in YRI
whose expression was shown to be correlated with distant
SNPs (p< 2.33 108, Pc< 0.05 after Bonferroni correction,
Table S3). Among all of these, two transcript clusters inCEU
and three transcript clusters in YRIwere shown to be associ-
ated with both local and distant SNPs. Some representative
SNPs are shown in Table 2. Among the transcript clusters
associated with local SNPs, three transcript clusters
(LOC646836, HIST1H3B [MIM*602819], SPATA20) (Fig-
ure 3) were found in both CEU and YRI samples.
Discussion
The Affymetrix GeneChip Human Exon 1.0 ST Array was
utilized to measure gene expression levels in EBV-trans-
formed LCLs derived from 176 healthy individuals (CEU:
87 cell lines; YRI: 89 cell lines).10 Gene-level expressions
were computed by the summarization of signals from
well-annotated exons (core set) within each transcript clus-
ter. To identify differentially expressed genes between the
CEU and YRI samples, we compared the expression levels
of 9156 transcript clusters that appeared to be reliably ex-
pressed. The proportion of expressed genes we deﬁned is
comparable to previous observations in LCLs.7 Using two
Table 1. Enriched Gene-Ontology Biological Processes in the
Gene Differentially Expressed between the CEU and YRI
Samples
GO ID
Biological
Process Gene Symbol Pa Pc
b
GO:7046 ribosome
biogenesis
BMS1L; GTPBP4;
UTP14C;
UTP14A
0.00036 0.04
GO:19735 antimicrobial
humoral
response
(sensu
Vertebrata)
SH2B2; CXCR3;
CCR7; MGST3;
CD53; MASP2
0.0011 0.042
GO:8033 tRNA
processing
PUS3; QTRT1;
TRMU; TRUB1;
WDR4
0.002 0.07
GO:184 mRNA
catabolism,
nonsense-
mediated
decay
UPT2; GSPT1;
UPF3A
0.0042 0.076
GO:16337 cell-cell
adhesion
NPHP4; ICAM5;
CD44
0.0081 0.01
a Nominal p values.
b Adjusted p values after BH correction.The Aindependent statistical approaches, we identiﬁed 383 tran-
script clusters whose expression was signiﬁcantly dif-
ferent between the CEU and YRI samples. A majority of
the differential transcript clusters identiﬁed with the two
approaches (93% for the W-Y approach and 83% for the
linearmodel) were consistent. TheW-Yapproach considers
dependence between genes when testing expression,
whereas the general linear model approach accounts for
the dependence between parents and offspring within
each trio. The average absolute difference in mean expres-
sion levels was 1.26-fold, consistent with the previous data
that the differences in gene expression level between pop-
ulations, albeit signiﬁcant, are not dramatic.17 Among
these 383 transcript clusters, nine genes (DPYSL2 [MIM
*602463], CTTN [MIM *164765], PLCG1 [MIM *172420],
SS18 [MIM *600192], SH2B3 [MIM *605093], CPNE9,
CMAH [MIM *603209], CXCR3 [MIM *300574], and
MRPS7) were reported by Storey et al. in their top 50 differ-
ential gene list17 from 16 CEU and YRI samples.
One potential problemwith the use of expressionmicro-
arrays is that oligonucleotide hybridization could be af-
fected by polymorphisms located within probes.36 It has
been shown that sequence polymorphisms can result in
many false positives when testing for cis eQTLs.37 The
same effect was also observed in our exon-array expression
data. For example, we detected a differential level of gene
expression of HLA-DPB1 [MIM*142858] between the CEU
and YRI samples by using the unﬁltered expression data.
Further examination indicated that the genotype of SNP
rs1042448 located in one of the probes at the 30-UTR in
HLA-DPB1 had a dramatic effect upon the overall expres-
sion of the gene. The ‘‘A’’ allele, which associated with
lower HLA-DPB1 expression, has lower allele frequency
in the CEU samples (Fst ¼ 0.16) (Figure S1). However, pre-
vious studies did not consider this potentially confound-
ing effect on the evaluation of gene expression.17 Thus,
to prevent confounding interpretations of gene expression
variation, we conservatively removed probesets that con-
tained two or more probes harboring SNPs before summa-
rizing expression.
One potential cause for the observed gene-expression
differences between populations could be the inﬂuence
of copy-number variation (CNV). We queried the Database
for Genomic Variants,38,39 which contains the CNV data
on the HapMap samples. We did not observe a higher per-
centage of CNVs among the 383 transcript clusters (12.5%,
Table S1) as compared to the entire analysis set (12.7%). In
other words, a majority of the differential transcript clus-
ters we identiﬁed were not within genomic regions of
known CNVs. Therefore, it is unlikely that CNV is a major
contributor to the expression differences we observed,
though the detailed contribution of CNVs to the differen-
tial expression at an individual level is not clear.
To further explore the biological functions of these dif-
ferentially expressed genes, we searched the GO30 and
KEGG32 databases for enriched biological processes or
known pathways in the genes that are differentiallymerican Journal of Human Genetics 82, 631–640, March 2008 635
Table 2. Local and Distant eQTL Regions Associated with Differential Expression between the CEU and YRI Samples
Affymetrix
Transcript-Cluster ID Symbol
eQTL
Chromosome
eQTLRegion
Starta
eQTL
Region Enda Mode
Number of
SNPs in eQTL Regionb
2336585 LOC653511; SCP2 1 53058601 53210718 CEU_local 23
2576554 LOC646836 2 131946053 131983007 CEU_local 12
2946215 HIST1H3B 6 25891888 26235250 CEU_local 50
3243262 HSD17B7P2;
LOC728924
10 37887922 38830434 CEU_local 50
3726569 SPATA20 17 45980827 45991533 CEU_local 4
3757602 LGP2 17 37510689 37547551 CEU_local 21
2576554 LOC646836 2 131942868 132009907 YRI_local 10
2676009 TWF2 3 52239947 52268899 YRI_local 5
2927722 HEBP2 6 138734108 138771357 YRI_local 19
2946215 HIST1H3B 6 25990621 26232222 YRI_local 4
3726569 SPATA20 17 45968836 45991533 YRI_local 7
2405893 C1orf212 17 63001411 63003236 CEU_distant 2
2576554 LOC646836 6 4013334 4014132 CEU_distant 2
3404436 CLEC2D 3 114568124 114583501 CEU_distant 2
3404436 CLEC2D 3 170414733 170425874 CEU_distant 3
3704495 APRT 3 56842045 56857103 CEU_distant 5
3726569 SPATA20 5 57560034 57578585 CEU_distant 8
4011989 CXCR3 1 61141307 61148816 CEU_distant 3
2342576 ACADM 2 156219672 156230250 YRI_distant 2
2676009 TWF2 2 182593683 182634395 YRI_distant 5
2757347 TMEM129 21 16516008 16517542 YRI_distant 3
2830861 EGR1 13 20552246 20552534 YRI_distant 2
2830861 EGR1 15 47728289 47738173 YRI_distant 5
2946215 HIST1H3B 5 37591074 37592683 YRI_distant 3
3119945 GRINA 16 79004853 79025950 YRI_distant 4
3138414 ARMC1 2 22100308 22182977 YRI_distant 2
3150844 SNTB1 6 55926914 55960696 YRI_distant 9
3430552 PWP1 17 64946645 64949581 YRI_distant 2
3528115 KIAA0737 3 83259569 83287824 YRI_distant 3
3528115 KIAA0737 13 74765674 74769331 YRI_distant 2
3528115 KIAA0737 16 69926323 69944391 YRI_distant 3
3528115 KIAA0737 17 45912325 45921701 YRI_distant 3
3528115 KIAA0737 21 21433634 21439258 YRI_distant 2
3597977 TRIP4 12 100519345 100522642 YRI_distant 3
3726569 SPATA20 10 51182135 51185540 YRI_distant 2
3755862 IKZF3 8 53290604 53290675 YRI_distant 2
3755862 IKZF3 10 106900641 106901321 YRI_distant 2
3774635 FASN 1 94702933 94744451 YRI_distant 2
3840058 PPP2R1A 4 139332786 139333979 YRI_distant 2
3850278 TYK2 9 23187975 23209634 YRI_distant 3
a indicates that SNP position information was from dbSNP version 126.
b indicates that these eQTL regions contain at least two SNPs with internal distance less than 200 Kb; other eQTLs are shown in Table S3.expressed between these two populations. Two GO bio-
logical processes, ribosome biogenesis and antimicrobial
humoral response (sensu Vertebrata), were found to be en-
riched in our gene set (Table 1). It has been reported that
African Americans may be more susceptible to infection
by certain bacteria than are individuals of European ances-
try.40 Also, some genetic polymorphisms carried in the
African-American population have been shown to lead to
different antimicrobial response.41 Therefore, our ﬁndings
that differentially expressed genes are enriched in antimi-
crobial humoral response could be used to evaluate these
clinical observations. Using 16 samples, Storey et al. found
that their differentially expressed genes were strongly en-
riched in inﬂammatory pathways17 and included two cyto-
kine receptors (CCR7 [MIM*600242] and CXCR3), which636 The American Journal of Human Genetics 82, 631–640, Marchalso showed up in our list. In addition, at a less-stringent
cutoff (Pc < 0.10 after BH correction), three more GO bio-
logical processes were found to be enriched: cell-cell adhe-
sion, mRNA catabolism (nonsense-mediated decay), and
tRNA processing (Table 1). Interestingly, several of these
systems might further modulate overall gene expression,
making populations more similar or different. The fact
that such biological processes as ribosomal biogenesis
and tRNA processing are enriched in the differentially ex-
pressed genes suggests their possible roles in contribution
to the population differences at a level higher than that
of mRNA expression. Strikingly, a defect within a gene
linked to a tRNA has been reported to contribute to a broad
range of cell malfunctions that may lead to heart disease
and stroke.42 At Pc < 0.05, a search for enriched KEGG2008
pathways within our gene set did not identify any known
pathways. When a more lenient cutoff of Pc < 0.20 after
BH correction was used, one pathway, the Notch-signaling
pathway (p ¼ 0.004), was found to be enriched in the dif-
ferential genes. The Notch-signaling pathway has a wide-
spread role in development and has been associated with
several human diseases, including many types of cancer.43
This pathway was also found by Storey et al. to be enriched
in the top 10% of differential genes between CEU and YRI,
but only when a nominally signiﬁcant p value with no
multiple test correction was used.17
We then evaluated the genetic contributions to the
observed differences in expression between the CEU and
YRI samples. We carried out a genome-wide eQTL analysis
to identify the local and distant genetic variants that regu-
late the 383 transcript clusters’ expression using the pub-
licly available SNPmarkers from the International HapMap
Project.9,10 Gene expression associated with any SNP
Figure 3. Gene Expression Regulated
by Local eQTLs
Three differentially expressed genes are
regulated by the same local eQTLs in CEU
(red) and YRI (blue) populations.
(A) and (B) show that the higher expres-
sion of LOC646836 in CEU is regulated by
SNP rs7424438 (Fst ¼ 0.21).
(C) and (D) show that the higher expres-
sion of HIST1H3B in CEU is regulated by
SNP rs198820 (Fst ¼ 0.16).
(E) and (F) show that the higher expression
of SPATA20 in CEU is regulated by
rs8076470 (Fst ¼ 0.22).
The numbers below the boxplots in (B),
(D), and (F) are the genotype counts of
the SNPs.
within 2.5 Mb on the same chromo-
some was deﬁned as locally associ-
ated, and gene expression associated
with any SNP on a different chromo-
some or more than 2.5 Mb away on
the same chromosome was deﬁned
as distantly associated. The Bonfer-
roni correction provided us with
a list of SNPs whose associations
with differential expression were
the most striking. Among the tran-
script clusters associated with local
SNPs, three (LOC646836, HIST1H3B,
SPATA20) were found in both CEU
and YRI samples (Figure 3, Table 2).
The allele-frequency-driven gene-
expression difference between the
CEU and YRI samples is further illus-
trated in Figure 3, which shows the
relationship between some represen-
tative SNPs for the three locally asso-
ciated transcript clusters and gene expression in both
populations.
Because of the differences in cell-line collection time be-
tween theCEU andYRI samples,10,18 expression differences
could be a combined effect of both genetic and nongenetic
factors. In addition, culture conditions or batch-to-batch
variation could inﬂuence the observed differences in gene
expression between the two populations.16 Therefore, to
reduce these variables, cell cultureprotocolswereoptimized
and samples (CEU and YRI) were randomized when cul-
turedandhybridized.We further testedwhetherpopulation
identity (whichwould include any effects due to collection-
time differences) remained a signiﬁcant predictor of gene
expression when the association between genotype and
expression was modeled. For a subset of moderate eQTLs
(including all local SNPs and distant high-frequency SNPs
having at least two counts for each genotype), with a less
stringent cutoff than the previous QTDT test (p < 0.001),
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360 differential transcript clusters were shown to be regu-
latedby local and/ordistantSNPs (Figure4)withpopulation
identity no longer a signiﬁcant predictor. In other words,
a majority of the differential transcript clusters (94%) are
not explained simply by population identity alone. While
our results conﬁrmed that common genetic variants ac-
count for a substantial fraction of the observed differences
in gene expression, some nongenetic factors could still
contribute to the observed population differences in gene
expression in these samples. Previous studies have focused
on cis-acting elements,17 but our results suggest that distant
or trans-acting elements can also contribute substantially to
the population differences in gene expression. Thus, it is
possible that various cis- and trans-acting elements interact
as part of a complete network of regulation of complex
traits. Our ﬁndings of signiﬁcant SNP and transcript cluster
associations, therefore, can be targets for further functional
validation to investigate these regulation mechanisms.
Impressively, both the two previous studies (Spielman
et al. and Storey et al.) and the current study utilized the
HapMap LCL samples and reported the contribution of
common variants to the differential expression between
populations. However, there were differences in study
design (e.g., sample size, number of genes on chips, micro-
array technology,44 consideration of SNPs in probes, and
different statistical approaches) that would account for
the discrepancy in these studies. Although the reproduc-
ibility of the exon arrays is generally high,19,20 one limita-
tion of this work is that technical replicates were not
available for these samples, thus limiting our discussion
to only sets of genes that are differentially expressed
between populations. For a more comprehensive view of
gene expression, one would need to consider interindivid-
ual and interpopulation variation together.
Figure 4. Evaluation of the Contribution of Nongenetic
Factors to Gene-Expression Variation
A majority of the differential transcript clusters are not ex-
plained simply by population identity alone. Each point repre-
sents an association of an SNP with an expression phenotype.
The y axis is the p value of the likelihood test (see Methods).
The vertical line represents the Fst value cutoff (Fst ¼ 0.15).
The horizontal line represents the p value cutoff (p ¼ 0.001).
(A) Red points indicate 19 transcript clusters whose expression
levels are driven by allele frequency of local SNPs.
(B) Red points indicate 341 transcript clusters whose expres-
sion levels are driven by allele frequency of distant SNPs.
Supplemental Data
Supplemental data include one ﬁgure and three tables and can
be found with this article online at http://www.ajhg.org/.
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